Therefore, we have generated and characterized a novel rFab’ anti-PD-L1 and demonstrated its ability to suppress proliferation, migration and invasion of HNSCC cells by inhibiting p-AKT and p-ERK as well as EMT and to enhance the cytotoxic effect of cisplatin. Here, AKT1 is linked to head and neck squamous cell carcinoma.